Effectiveness of implementation strategies for clinical guidelines to community pharmacy: a systematic review

Implementation Science

Rhonda Clifford¹  Carl R. Schneider²  Helen Wood¹  Kim Watkins¹ 

[1] School of Medicine and Pharmacology, University of Western Australia, Perth, Australia;Faculty of Pharmacy, The University of Sydney, Sydney, Australia

关键词: Evidence-based medicine;    Guideline;    Information dissemination;    Implementation;    Pharmacists;    Pharmacy;    Community pharmacy;   

Others  :  1230930
DOI  :  10.1186/s13012-015-0337-7

 received in 2015-06-17, accepted in 2015-10-13,  发布年份 2015

【 摘 要 】

Background

The clinical role of community pharmacists is expanding, as is the use of clinical guidelines in this setting. However, it is unclear which strategies are successful in implementing clinical guidelines and what outcomes can be achieved. The aim of this systematic review is to synthesise the literature on the implementation of clinical guidelines to community pharmacy. The objectives are to describe the implementation strategies used, describe the resulting outcomes and to assess the effectiveness of the strategies.

Methods

A systematic search was performed in six electronic databases (Medline, EMBASE, CINAHL, Web of Science, Informit, Cochrane Library) for relevant articles. Studies were included if they reported on clinical guidelines implementation strategies in the community pharmacy setting. Two researchers completed the full-search strategy, data abstraction and quality assessments, independently. A third researcher acted as a moderator. Quality assessments were completed with three validated tools. A narrative synthesis was performed to analyse results.

Results

A total of 1937 articles were retrieved and the titles and abstracts were screened. Full-text screening was completed for 36 articles resulting in 19 articles (reporting on 22 studies) included for review. Implementation strategies were categorised according to a modified version of the EPOC taxonomy. Educational interventions were the most commonly utilised strategy (n = 20), and computerised decision support systems demonstrated the greatest effect (n = 4). Most studies were multifaceted and used more than one implementation strategy (n = 18). Overall outcomes were moderately positive (n = 17) but focused on process (n = 22) rather than patient (n = 3) or economic outcomes (n = 3). Most studies (n = 20) were rated as being of low methodological quality and having low or very low quality of evidence for outcomes.

Conclusions

Studies in this review did not generally have a well thought-out rationale for the choice of implementation strategy. Most utilised educational strategies, but the greatest effect on outcomes was demonstrated using computerised clinical decision support systems. Poor methodology, in the majority of the research, provided insufficient evidence to be conclusive about the best implementation strategies or the benefit of clinical guidelines in this setting. However, the generally positive outcomes across studies and strategies indicate that implementing clinical guidelines to community pharmacy might be beneficial. Improved methodological rigour in future research is required to strengthen the evidence for this hypothesis.

Protocol registration

PROSPERO 2012:CRD42012003019.

【 授权许可】

   
2015 Watkins et al.

【 图 表 】

Fig. 1.

Fig. 1.

【 参考文献 】

• [1]Francke AL, Smit MC, de Veer AJ, Mistiaen P. Factors influencing the implementation of clinical guidelines for health care professionals: a systematic meta-review. BMC Medical Informatics & Decision Making. 2008;8(38) doi:. 10. 1186/1472-6947-8-38 webcite
• [2]Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L et al.. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004; 8(6):iii-iv.
• [3]Pilling S. History, context, process, and rationale for the development of clinical guidelines. Psychol Psychotherapy. 2008; 81(Pt 4):331-50.
• [4]Woolf SH, Grol R, Hutchinson A, Eccles M, Grimshaw J. Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines. BMJ (Clinical research ed). 1999; 318(7182):527-30.
• [5]Field MJ, Lohr KN. Clinical practice guidelines: directions for a new program. vol IOM publication; 90–08. National Academy Press, Washington D.C; 1990.
• [6]Grimshaw J, Russell I. Effect of clinical guidelines on medical practice: a systematic review of rigorous evaluations. Lancet. 1993; 342(88883):1317-22.
• [7]Runciman WB, Hunt TD, Hannaford NA, Hibbert PD, Westbrook JI, Coiera EW et al.. CareTrack: assessing the appropriateness of health care delivery in Australia. Med J Aust. 2012; 197(2):100-5.
• [8]Grol R, Buchan H. Clinical guidelines: what can we do to increase their use? Med J Aust. 2006; 185(6):301-2.
• [9]Grol R, Grimshaw J. From best evidence to best practice: effective implementation of change in patients’ care. Lancet. 2003; 362(9391):1225-30.
• [10]Colagiuri R. Implementing evidence based guidelines: unlocking the secrets. Diabetes Res Clin Pract. 2009; 85(2):117-8.
• [11]Fretheim A, Schunemann HJ, Oxman AD. Improving the use of research evidence in guideline development: 15. Disseminating and implementing guidelines. Health Res Policy Syst. 2006; 4:27. BioMed Central Full Text
• [12]National Health and Medical Research Council. In: A guide to the development, implementation and evaluation of clinical practice guidelines. 1999. Canberra: AusInfo Government Info Bookshops.
• [13]Thomas L, Cullum N, McColl E, Rousseau N, Soutter J, Steen N. Guidelines in professions allied to medicine. Cochrane Database Syst Rev. 2009; 1:CD000349.
• [14]Squires JE, Sullivan K, Eccles MP, Worswick J, Grimshaw JM. Are multifaceted interventions more effective than single-component interventions in changing health-care professionals’ behaviours? An overview of systematic reviews. Implement Sci. 2014; 9:152.
• [15]Wensing M, van der Weijden T, Grol R. Implementing guidelines and innovations in general practice: which interventions are effective? Br J Gen Pract. 1998; 48(427):991-7.
• [16]Hakkennes S, Dodd K. Guideline implementation in allied health professions: a systematic review of the literature. Qual Saf Health Care. 2008; 17(4):296-300.
• [17]Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S et al.. Tailored interventions to address determinants of practice. Cochrane Database Syst Rev. 2015; 4:CD005470.
• [18]Galgliardi AR, Alhabib S. Members of the Guidelines International Network Implementation Working Group. Trends in guideline implementation: a scoping systematic review. Implement Sci. 2015; 10:54. BioMed Central Full Text
• [19]Eccles MP, Grimshaw JM, MacLennan G, Bonetti D, Glidewell L, Pitts NB et al.. Explaining clinical behaviors using multiple theoretical models. Implement Sci. 2012; 7:99. BioMed Central Full Text
• [20]Designing theoretically-informed implementation interventions. Implement Sci. 2006; 1:4. BioMed Central Full Text
• [21]Michie S, van Stralen MM, West R. The behaviour change wheel: a new method for characterising and designing behaviour change interventions. Implement Sci. 2011; 6:42.
• [22]Scott SD, Albrecht L, O’Leary K, Ball GD, Hartling L, Hofmeyer A et al.. Systematic review of knowledge translation strategies in the allied health professions. Implement Sci. 2012; 7:70.
• [23]Davies P, Walker AE, Grimshaw JM. A systematic review of the use of theory in the design of guideline dissemination and implementation strategies and interpretation of the results of rigorous evaluations. Implement Sci. 2010; 5:14.
• [24]Freemantle N. Implementation strategies. Fam Pract. 2000; 17 Suppl 1:S7-10.
• [25]Grol R. Implementing guidelines in general practice care. Qual Health Care. 1992; 1(3):184-91.
• [26]Worrall G, Chaulk P, Freake D. The effects of clinical practice guidelines on patient outcomes in primary care: a systematic review. CMAJ. 1997; 156(12):1705-12.
• [27]Habeeb Ibrahim AR, Deepak J, Jegan RS. Pharmacists in the wider public health workforce. Arch Pharm Pract. 2012; 3(2):166-9.
• [28]Mossialos E, Naci H, Courtin E. Expanding the role of community pharmacists: policymaking in the absence of policy-relevant evidence? Health Policy. 2013; 111(2):135-48.
• [29]Liberati A, Altman DG, Tetzlaff J, Mulrow C, Gotzsche PC, Ioannidis JP et al.. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009; 62(10):e1-34.
• [30]Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Journal of Clinical Epidemiology. 2009;62(10):1006–12. http://dx. doi.org/10.1016/j.jclinepi.2009.06.005 webcite
• [31]Watkins K, Wood H, Schneider C, Clifford R. Clinical guideline implementation in community pharmacy. (PROSPERO) International prospective register of systematic reviews, 2012 CRD42012003019.
• [32]Morrison A, Polisena J, Husereau D, Moulton K, Clark M, Fiander M et al.. The effect of English-language restriction on systematic review-based meta-analyses: a systematic review of empirical studies. Int J Technol Assess Health Care. 2012; 28(2):138-44.
• [33]Huang X, Lin J, Demner-Fushman D. Evaluation of PICO as a knowledge representation for clinical questions. AMIA. [Evaluation Studies]. 2006;Annual Symposium Proceedings/AMIA Symposium 2006 359-63. Available from: MEDLINE.
• [34]Moullin JC, Sabater-Hernández D, Fernandez-Llimos F, Benrimoj SI. Defining professional pharmacy services in community pharmacy. Res Soc Adm Pharm. 2013; 9(6):989-95.
• [35]Armour C, Bosnic-Anticevich S, Brillant M, Burton D, Emmerton L, Krass I et al.. Pharmacy Asthma Care Program (PACP) improves outcomes for patients in the community. Thorax. 2007; 62(6):496-502.
• [36]EPOC taxonomy. Norwegian Knowledge Centre for the Health Services, Oslo; 2015. http://epoc. cochrane.org/epoc-taxonomy
• [37]Baker R, Camosso-Stefinovic J, Gillies C, Shaw EJ, Cheater F, Flottorp S et al.. Tailored interventions to overcome identified barriers to change: effects on professional practice and health care outcomes. Cochrane Database Syst Rev. 2010; 3:CD005470.
• [38]Chaudoir SR, Dugan AG, Barr CH. Measuring factors affecting implementation of health innovations: a systematic review of structural, organizational, provider, patient, and innovation level measures. Implement Sci. 2013; 8:22.
• [39]Benrimoj SC, Gilbert A, Quintrell N, Neto AC. Non-prescription medicines: a process for standards development and testing in community pharmacy. Pharm World Sci. 2007; 29(4):386-94.
• [40]Benrimoj SI, Gilbert AL, de Almeida Neto AC, Kelly F. National implementation of standards of practice for non-prescription medicines in Australia. Pharm World Sci. 2009; 31(2):230-7.
• [41]Mestrovic A, Stanicic Z, Hadziabdic MO, Mucalo I, Bates I, Duggan C et al.. Individualized education and competency development of Croatian community pharmacists using the general level framework. Am J Pharm Educ. 2012; 76(2):23.
• [42]Paphassarang C, Wahlstrom R, Phoummalaysith B, Boupha B, Tomson G. Building the national drug policy on evidence—a cross sectional study on assessing implementation in Lao PDR. Southeast Asian J Trop Med Public Health. 2002; 33(3):647-53.
• [43]Cochrane Effective P. What outcomes should be reported in EPOC reviews? EPOC resources for review authors. Norwegian Knowledge Centre for the Health Services, Oslo; 2013. http://epoc. cochrane.org/sites/epoc.cochrane.org/files/uploads/06%20What%20outcomes%20should%20be%20reported%20in%20EPOC%20reviews%202013%2008%2012_1.pdf
• [44]Rothstein JM. On defining subjective and objective measurements. Phys Ther. 1989; 69(7):577-9.
• [45]Des Jarlais DC, Lyles C, Crepaz N, Group T. Improving the reporting quality of nonrandomized evaluations of behavioral and public health interventions: the TREND statement. Am J Public Health. 2004; 94(3):361-6.
• [46]The Cochrane Collaboration. Data collection form: Intervention review RCTs and non-RCTs. 2014. http://community. cochrane.org/sites/default/files/uploads/forums/u389/ERC%20data%20collection%20form%20for%20intervention%20reviews%20for%20RCTs%20only.doc webcite
• [47]Cochrane Effective Practice and Organisation of Care Group (EPOC). Suggested risk of bias criteria for EPOC reviews. Oslo: Norwegian Knowledge Centre for the Health Services 2013. http://epoc. cochrane.org/sites/epoc.cochrane.org/files/uploads/14%20Suggested%20risk%20of%20bias%20criteria%20for%20EPOC%20reviews%2009%2002%2015.pdf webcite
• [48]Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. 2011. http://www. ohri.ca/programs/clinical_epidemiology/nosgen.pdf webcite
• [49]Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration,. http://handbook. cochrane.org/chapter_9/9_1_4_when_not_to_use_meta_analysis_in_a_review.htm webcite
• [50]Deeks JJ, Dinnes J, D’Amico R, Sowden AJ, Sakarovitch C, Song F et al.. Evaluating non-randomised intervention studies. Health Technol Assess. 2003; 7(27):iii-x.
• [51]Guyatt GH, Oxman AD, Vist GE, Kunz R, Falck-Ytter Y, Alonso-Coello P et al.. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 336(7650):924-6.
• [52]Guyatt GH, Oxman AD, Vist G, Kunz R, Brozek J, Alonso-Coello P et al.. GRADE guidelines: 4. Rating the quality of evidence—study limitations (risk of bias). J Clin Epidemiol. 2011; 64(4):407-15.
• [53]EPOC worksheets for preparing a summary of findings (SoF) table using GRADE. Norwegian Knowledge Centre for the Health Services, Oslo; 2013. http://epoc. cochrane.org/epoc-specific-resources-review-authors
• [54]Curtain C, Peterson GM, Tenni P, Bindoff IK, Williams M. Outcomes of a decision support prompt in community pharmacy-dispensing software to promote step-down of proton pump inhibitor therapy. Br J Clin Pharmacol. 2011.
• [55]De Almeida Neto AC, Benrimoj SI, Kavanagh DJ, Boakes RA. Novel educational training programme for community pharmacists. Am J Pharmaceut Educ. 2000; 64(Fall 2000):302-7.
• [56]De Almeida Neto AC, Kelly F, Benrimoj SI. Shaping practice behaviour: novel training methodology (study 1). Int J Pharm Pract. 2001; 9(3):203-10.
• [57]Kradjan WA. Patients’ perceived benefit from and satisfaction with asthma-related pharmacy services. J Am Pharm Assoc. 1999; 39(5):658.
• [58]Patwardhan PD, Chewning BA. Effectiveness of intervention to implement tobacco cessation counseling in community chain pharmacies. J Am Pharm Assoc. 2012.
• [59]Raisch DW. Effect of a pharmacist-education initiative on ketorolac use and costs in a Medicaid program. Am J Health Syst Pharm. 1998; 55(12):1274.
• [60]Reeve JF, Tenni PC, Peterson GM. An electronic prompt in dispensing software to promote clinical interventions by community pharmacists: a randomized controlled trial. Br J Clin Pharmacol. 2008.
• [61]Van de Steeg-van Gompel CH, Wensing M, De Smet PA. Implementation of patient education at first and second dispensing of statins in Dutch community pharmacies: the sequel of a cluster randomized trial. BMC Health Serv Res. 2011; 11:313.
• [62]Watson MC, Bond CM, Grimshaw JM, Mollison J, Ludbrook A, Walker AE. Educational strategies to promote evidence-based community pharmacy practice: a cluster randomized controlled trial (RCT). Fam Pract. 2002; 19(5):529-36.
• [63]Watson MC, Cleland J, Inch J, Bond CM, Francis J. Theory-based communication skills training for medicine counter assistants to improve consultations for non-prescription medicines. Med Educ. 2007; 41(5):450-9.
• [64]De Almeida Neto AC, Kelly F, Benrimoj SI. Shaping practice behaviour: novel training methodology (study 3). Int J Pharm Pract. 2001; 9(3):203-10.
• [65]Naunton M, Peterson GM, Jones G, Griffin GM, Bleasel MD. Multifaceted educational program increases prescribing of preventive medication for corticosteroid induced osteoporosis. J Rheumatol. 2004; 31(3):550-6.
• [66]Sigrist T, Benrimoj SI, Hersberger K, Langford J. Changing pharmacists’ and pharmacist assistants' practice in dealing with direct requests for non-prescription analgesics. 2002. doi:10.1111/j.2042-7174.2002.tb00584.x
• [67]Legrand SA, Boets S, Meesmann U, Verstraete AG. Medicines and driving: evaluation of training and software support for patient counselling by pharmacists. Int J Clin Pharm. 2012; 34(4):633-43.
• [68]De Almeida Neto AC, Kelly F, Benrimoj SI. Shaping practice behaviour: novel training methodology (study 5). Int J Pharm Pract. 2001; 9(3):203-10.
• [69]De Almeida Neto AC, Kelly F, Benrimoj SI. Shaping practice behaviour: novel training methodology (study 5A). Int J Pharm Pract. 2001; 9(3):203-10.
• [70]Egen V, Hasford J. Prevention of neural tube defects: effect of an intervention aimed at implementing the official recommendations. Soz Praventivmed. 2003; 48(1):24-32.
• [71]Guirguis LM, Schindel TJ, Johnson JA, Tsuyuki RT. Evaluating pharmacists’ experience using diabetes practice tools: a pilot study. Can Pharm J. 2007; 140(5):312-9.
• [72]Koster ES, Walgers JCD, van Grinsven MCJ, Winters NA, Bouvy ML. Adherence to national recommendations for safe Methotrexate dispensing in community pharmacies. J Manag Care Pharm. 2014; 20(2):194-200.
• [73]Martin BA, Bruskiewitz RH, Chewning BA. Effect of a tobacco cessation continuing professional education program on pharmacists’ confidence, skills, and practice-change behaviors. J Am Pharm Assoc (2003). 2010; 50(1):9-16.
• [74]Puumalainen I, Kansanaho H, Varunki M, Ahonen R, Airaksinen M. Usefulness of the USP medication counselling behavior guidelines. Pharm World Sci. 2005; 27(6):465-8.
• [75]Thornley T, Gray N, Anderson C, Eastham S. A study to investigate the extent of delivery of an intervention in asthma, in a UK national community pharmacy chain, using mystery customers. Patient Educ Couns. 2006; 60(2):246-52.
• [76]Grimshaw J, Campbell M, Eccles M, Steen N. Experimental and quasi-experimental designs for evaluating guideline implementation strategies. Fam Pract. 2000; 17 Supplement:s11-6.
• [77]McCambridge J, Witton J, Elbourne DR. Systematic review of the Hawthorne effect: new concepts are needed to study research participation effects. J Clin Epidemiol. 2014; 67(3):267-77.
• [78]Watson M, Skelton J, Bond C, Croft P, Wiskin C, Grimshaw J et al.. Simulated patients in the community pharmacy setting. Pharm World Sci. 2004; 26:32-7.
• [79]Peterson G, Tenni P, Jackson S, Bereznicki L, Hughes J, Kong D, et al. Documenting Clinical Interventions in Community Pharmacy: PROMISe III 2010.
• [80]Dexheimer JW, Borycki EM, Chiu KW, Johnson KB, Aronsky D. A systematic review of the implementation and impact of asthma protocols. BMC Med InformDecision Making. 2014; 14:82.
• [81]Forsetlund L, Bjorndal A, Rashidian A, Jamtvedt G, O’Brien MA, Wolf F et al. Continuing education meetings and workshops: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews. 2009(2):CD003030. http://dx. doi.org/10.1002/14651858.CD003030.pub2 webcite
• [82]Krause J, Van Lieshout J, Klomp R, Huntink E, Aakhus E, Flottorp S et al. Identifying determinants of care for tailoring implementation in chronic diseases: an evaluation of different methods. Implement Sci. 2014;9:102. http://dx. doi.org/10.1186/s13012-014-0102-3 webcite
• [83]French SD, Green SE, O’Connor DA, McKenzie JE, Francis JJ, Michie S et al. Developing theory-informed behaviour change interventions to implement evidence into practice: a systematic approach using the Theoretical Domains Framework. Implement Sci. 2012;7:38. http://dx. doi.org/10.1186/1748-5908-7-38 webcite
• [84]Nilsen P. Making sense of implementation theories, models and frameworks. Implement Sci. 2015;10:53. http://dx. doi.org/10.1186/s13012-015-0242-0 webcite
• [85]Mandt I, Horn AM, Ekedahl A, Granas AG. Community pharmacists’ prescription intervention practices—Exploring variations in practice in Norwegian pharmacies. Research in Social and Administrative Pharmacy. 2010;6(1):6–17. http://dx. doi.org/10.1016/j.sapharm.2009.03.003 webcite
• [86]Garg AX, Adhikari NK, McDonald H, Rosas-Arellano MP, Devereaux PJ, Beyene J et al.. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. JAMA. 2005; 293(10):1223-38.
• [87]Hakkennes S, Green S. Measures for assessing practice change in medical practitioners. Implement Sci. 2006; 1:29. BioMed Central Full Text
• [88]Schneider CR, Everett AW, Geelhoed E, Kendall PA, Murray K, Garnett P et al.. Provision of primary care to patients with chronic cough in the community pharmacy setting. Ann Pharmacother. 2011; 45(3):402-8.
• [89]Watson M, Bond C, Grimshaw J, Johnston M. Factors predicting the guideline compliant supply (or nonsupply) of non-prescription medicines in the community pharmacy setting. Quality Safety Health Care. 2006; 15:53-7.
• [90]Foy R, Eccles M, Grimshaw J. Why does primary care need more implementation research? Fam Pract. 2001; 18(4):353-5.
• [91]Grol R, Jones R. Twenty years of implementation research. Fam Pract. 2000; 17 Suppl 1:S32-5.
• [92]Tavender EJ, Bosch M, Gruen RL, Green SE, Michie S, Brennan SE et al. Developing a targeted, theory-informed implementation intervention using two theoretical frameworks to address health professional and organisational factors: a case study to improve the management of mild traumatic brain injury in the emergency department. Implement Sci. 2015;10:74. http://dx. doi.org/10.1186/s13012-015-0264-7 webcite
• [93]Australian Government Department of Health and Ageing. Primary Health Care Reform in Australia: Report to Support Australia’s First National Primary Health Care Strategy. Commonwealth of Australia 2009. http://apo. org.au/files/Resource/NPHC-supp.pdf webcite
• [94]World Health Organization. The World Health Report 2008: Primary Health Care: Now More than Ever. 2008. http://www. who.int/whr/2008/whr08_en.pdf webcite
• [95]Watson MC, Norris P, Granas AG. A systematic review of the use of simulated patients and pharmacy practice research. International Journal of Pharmacy Practice. 2006;14(2):83–93. http://dx. doi.org/10.1211/ijpp.14.2.0002 webcite